It’s a Whole New World: Navigating Therapeutic Options for Endometrial Cancer, an Industry Supported Symposium at the 2024 SGO Winter Meeting

Activity Overview

The GOG Foundation, Inc. and GOG Partners welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to register for access to the It’s A Whole New World: Navigating Therapeutic Options for Endometrial Cancer Enduring Education Materials, an Industry Supported Symposium at the 2024 SGO Winter Meeting.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: AstraZeneca, GSK, and Karyopharm.

Target Audience

The target audience for this activity is community and academic gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other providers who treat patients with gynecologic malignancies.

Learning Objectives

Upon completion of the activities in this series, learners will demonstrate:

  • Review the current landscape for the treatment of advanced stage or recurrent endometrial cancer based on pivotal clinical trials and insights in 2023.
  • Discuss biomarker-based strategies to direct chemotherapy, radiation, combined chemoradiation, and biologic-targeted therapies.
  • Highlight novel therapies and current clinical trials for endometrial cancer.
  • Decipher how to best treat patients based on debates and discussion from Expert Faculty

Moderator


Dr. Mathew Powell

Faculty


Dr. Amanda Nickles-Fader

Dr. Floor Backes

Agenda & Presentation Materials

It’s A Whole New World: Navigating Therapeutic Options for Endometrial Cancer, an Industry Supported Symposium at the 2024 SGO Winter Meeting

Presented on Thursday, January 25 from 8:00 pm – 9:30 pm PT

Register To Access the Symposium Recording

8:00 pm – 8:05 pm
Welcome & Introductions – View Presentation
Matthew Powell, MD, Washington University, St. Louis, Missouri, USA
8:05 pm – 8:25 pm
Front-Line Trials and Current Landscape – View Presentation
Amanda Nickles-Fader, MD, Johns Hopkins University, Baltimore, Maryland, USA
8:25 pm – 8:45 pm
Emerging Novel Therapies and Clinical Trials, 2nd Line and Beyond – View Presentation
Floor Backes, MD, The Ohio State University, James Cancer Center, Columbus, Ohio, USA
8:45 pm – 9:10 pm
Debate: And The Science Says… – View Presentation
All Faculty
9:10 pm – 9:25 pm
Audience Q&A
All Faculty
9:25 pm – 9:30 pm
Wrap Up & Final RemarksView Presentation
Matthew Powell, MD, Washington University, St. Louis, Missouri, USA

Continuing Education

In support of improving patient care, this activity has been planned and implemented by The GOG Foundation, Inc. (GOG).

Accreditation Statement

The GOG Foundation, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians.

AMA PRA Category 1 Credits™

The GOG Foundation, Inc. designates this on demand activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Method of Participation

There are no fees for participating in and receiving CME credit for this activity. Participants must: 1) read the educational objectives and faculty disclosures; 2) attend the educational activity; 3) email our educational team at info@gog.org to receive and complete the educational evaluation.

Participants who complete the educational activity and evaluation will receive a certificate of credit.

Disclosure Declaration

In accordance with the ACCME Accreditation Criteria, The GOG Foundation, Inc., as the accredited provider of this activity, must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any ineligible company *(formally known as commercial interests). All Committee/Planning/Faculty members were required to disclose all financial relationships and speakers were required to disclose any financial relationship as it pertains to the content of the presentations. All relevant financial relationships listed for these individuals have been mitigated to ensure a bias-free presentation. Please see the faculty disclosure list for detailed information.

Faculty Disclosures

  • Floor Backes, MD, The Ohio State University, James Cancer Center, Columbus, Ohio, USA
  • Amanda Nickles-Fader, MD, Johns Hopkins University, Baltimore, Maryland, USA
  • Matthew Powell, MD, Washington University, St. Louis, Missouri, USA